Trimethylammonium

Trimethylammonium

SCHEMBL21056159

C=CC[N+](C)(C)C(C)O.CN(C)C.Cl.[Cl-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Trimethylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL131480 0.91 ACHE (0.31)
Hydrochloric Acid SCHEMBL900025 0.91 ACHE (0.31)
Hydrochloric Acid SCHEMBL29171340 0.89 ACHE (0.31)
SCHEMBL87577 0.89
Bromide SCHEMBL9778239 0.87 ACHE (0.34)
Water SCHEMBL11060381 0.87 ACHE (0.31)
Phosphoric Acid SCHEMBL28838497 0.79 BBOX1 (0.35)
SCHEMBL27798884 0.78 BBOX1 (0.34)
Propionic Acid SCHEMBL10458033 0.75 BBOX1 (0.43)
Hydrochloric Acid SCHEMBL3810774 0.73 ACHE (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894532-B1 AN ENCAPSULATED DYE COMPOSITION AND A METHOD FOR PREPARATION THEREOF HEUBACH HOLDING SWITZERLAND LTD (CH) 2024-03-27 EP disclosed
WO-2022128184-A1 MINIEMULSIONS COMPRISING SUPERHYDROPHOBIC AND/OR HYDROPHOBIC MONOMERS, METHOD OF PREPARING THE SAME AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2022-06-23 WO disclosed
EP-4015541-A1 MINIEMULSIONS COMPRISING SUPERHYDROPHOBIC AND/OR HYDROPHOBIC MONOMERS, METHOD OF PREPARING THE SAME AND USE THEREOF Clariant International Ltd (CH) 2022-06-22 EP disclosed
US-20210330560-A1 COSMETIC GEL COMPRISING A TRIGLYCERIDE OIL CLARIANT INTERNATIONAL LTD. (CH) 2021-10-28 US disclosed
EP-3894532-A1 AN ENCAPSULATED DYE COMPOSITION AND A METHOD FOR PREPARATION THEREOF Colorants International Ltd (CH) 2021-10-20 EP disclosed
EP-3628304-B1 COSMETIC GEL COMPRISING A TRIGLYCERIDE OIL CLARIANT INT LTD (CH) 2021-07-14 EP disclosed
EP-3498253-B1 VESICLES FOR DELAYED DELIVERY OF FRAGRANCE THEIR PREPARATION AND USE THEREOF CLARIANT INT LTD (CH) 2021-02-17 EP disclosed
EP-3763746-A1 METHOD FOR PREPARING MINIEMULSIONS COMPRISING SUPERHYDROPHOBIC MONOMERS Clariant International Ltd (CH) 2021-01-13 EP disclosed
US-20200360245-A1 Vesicles for delayed delivery of fragrance their preparation and use thereof CLARIANT INTERNATIONAL LTD. (CH) 2020-11-19 US disclosed
WO-2020120225-A1 AN ENCAPSULATED DYE COMPOSITION AND A METHOD FOR PREPARATION THEREOF CLARIANT PLASTICS & COATINGS LTD (CH) 2020-06-18 WO disclosed
EP-3666869-A1 AN ENCAPSULATED DYE COMPOSITION AND A METHOD FOR PREPARATION THEREOF Clariant Plastics & Coatings Ltd (CH) 2020-06-17 EP disclosed
WO-2020064771-A1 COSMETIC GEL COMPRISING A TRIGLYCERIDE OIL CLARIANT INTERNATIONAL LTD (CH) 2020-04-02 WO disclosed
EP-3628304-A1 COSMETIC GEL COMPRISING A TRIGLYCERIDE OIL Clariant International Ltd (CH) 2020-04-01 EP disclosed
WO-2019115621-A1 VESICLES FOR DELAYED DELIVERY OF FRAGRANCE THEIR PREPARATION AND USE THEREOF CLARIANT INTERNATIONAL LTD (CH) 2019-06-20 WO disclosed
EP-3498253-A1 VESICLES FOR DELAYED DELIVERY OF FRAGRANCE THEIR PREPARATION AND USE THEREOF Clariant International Ltd (CH) 2019-06-19 EP disclosed